Results 121 to 130 of about 68,105 (186)
Carbapenems, often regarded as the last line of defense in treatment of urinary tract infections and urosepsis caused by Escherichia coli, are under pressure from emerging resistance.
Mikaela M. Walker +8 more
doaj +1 more source
United European Gastroenterology Journal, Volume 14, Issue 9, November 2026.
Solaiman Ezzafzafi +2 more
wiley +1 more source
Ceftazidime and cefotaxime--the clinician's choice.
A review of two third-generation cephalosporins, ceftazidime and cefotaxime, is presented. Ceftazidime, often used as a single agent, has shown greater activity than cefotaxime against Pseudomonas aeruginosa and other Pseudomonas species ...
Puthucheary, S.D., Goldsworthy, P.J.
core
Ceftazidime-resistance in pediatric melioidosis: A case report and literature review
We report a first case of ceftazidime-resistant pediatric melioidosis involving a previously healthy seven-year-old boy who presented with right lobar pneumonia complicated with a 5-cm lung abscess.
Charles Dekun Lai +9 more
core +1 more source
Teklu Gebrehiwot Gebremichael,1 Hiluf Hindeya Gebreyesus,2 Alem Gebremariam1 1Clinical Pharmacy Unit, School of Pharmacy, College of Health Sciences, Mekelle University, Mekelle, Tigray, Ethiopia; 2Medical Physiology Unit, Biomedical Division, School of ...
Gebremichael TG +2 more
doaj
The aim of the current study is the loading of ceftazidime into the first generation of poly(propyleneimine) dendrimer (PPI-G1) to produce an effective drug delivery system against Pseudomonas aeruginosa.
Aghayari, M. +6 more
core
De novo infections caused by ceftazidime/avibactam-resistant KPC variants are rarely reported. We characterize the evolution of a KPC-8-producing Klebsiella pneumoniae strain involved in a primary infection without previous ceftazidime/avibactam ...
Mateo-Vargas, María Alejandra +5 more
core +1 more source
Amikacin activity against carbapenem-resistant <i>Klebsiella pneumoniae</i> without phenotypic aminoglycoside resistance: impact of aminoglycoside-modifying enzyme (AME) gene <i>aac(6')-Ib-cr in vitro</i> and <i>in vivo</i>. [PDF]
Kim J +13 more
europepmc +1 more source
Objective: To evaluate cefditoren in inducer-substrate combinations to screen for AmpC induction. Methods: 100 clinical isolates (25 P. aeruginosa, 25 E. cloacae, 14 M. morganii, 13 S. marcescens, 12 C. freundii, 7 P. rettgeri, and 4 E.
Coronel, Pilar +8 more
core +1 more source

